Entering the TWILIGHT Zone

Prepare to dive into the TWILIGHT trial with Dr. Craig Beavers.

0:00-0:22: Intro
0:23-1:01: Introduction of Dr. Craig Beavers
1:02-3:32: TWILIGHT Overview
3:33-6:31: Craig’s Overall Thoughts
6:32-8:39: Excluded Patients
8:40-10:17: Ticagrelor Monotherapy and Ischemic Outcomes
10:18-12:52: TWILIGHT and GLOBAL LEADERS
12:53-14:24: Final Thoughts
14:25-15:22: Closing/Craig’s Upcoming Podcast

References:

  • TWILIGHT: Mehran R, Baber U, Sharma SK, et al. Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med 2019;381:2032-2042.
  • GLOBAL LEADERS: Vranckx P, Valgimigli M, Juni P, et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet 2018;392:940-49.

Episode is Live

Published: Dec. 24, 2019 @ 4AM EditUnpublish

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: